Carregant...

Individualizing anti-metabolic treatment strategies for head and neck squamous cell carcinoma based on TP53 mutational status

BACKGROUND: Mutations in the TP53 tumor suppressor gene are common in HNSCC and correlate with radioresistance. Currently, there are no clinically available therapeutic approaches targeting p53 in HNSCC. Here we propose a strategy which uses TP53 mutational status to individualize anti-metabolic str...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Sandulache, Vlad C., Skinner, Heath D., Ow, Thomas J., Zhang, Aijun, Xia, Xuefeng, Luchak, James M., Wong, Lee-Jun C., Pickering, Curtis R., Zhou, Ge, Myers, Jeffrey N.
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3188683/
https://ncbi.nlm.nih.gov/pubmed/21720999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.26321
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!